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Abstract:  Human  T-cell  leukemia  virus  type  1  (HTLV-1)  has  a  reputation  for  being 
extremely difficult to study in cell culture. The challenges in propagating HTLV-1 has 
prevented a rigorous analysis of how these viruses replicate in cells, including the detailed 
steps involved in virus assembly. The details for how retrovirus particle assembly occurs 
are poorly understood, even for other more tractable retroviral systems. Recent studies on 
HTLV-1  using  state-of-the-art  cryo-electron  microscopy  and  fluorescence-based 
biophysical  approaches  explored  questions  related  to  HTLV-1  particle  size,  Gag 
stoichiometry in virions, and Gag-Gag interactions in living cells. These results provided 
new and exciting insights into fundamental aspects of HTLV-1 particle assembly—which 
are distinct from those of other retroviruses, including HIV-1. The application of these and 
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other novel biophysical approaches promise to provide exciting new insights into HTLV-1 
replication. 
Keywords: deltaretrovirus; lentivirus; spectroscopy; fluorescence; tomography 
 
1. Introduction 
Human T-cell leukemia virus type 1 (HTLV-1)  was the first  human retrovirus identified three 
decades ago when it was first isolated in the United States and subsequently in Japan  [1,2]. The 
discovery of HTLV-1 and its demonstration as the etiological agent of adult T-cell leukemia (ATL) 
has  been  previously  reviewed  [3–5].  HTLV-1  presently  infects  about  20  million  individuals  
worldwide  [6],  and  viral  infection  can  also  result  in  an  inflammatory  disease  syndrome  called  
HTLV-1-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) [7,8]. Prevalence rates for 
HTLV-1  infection  in  the  general  population  are  greater  than  1%  in the Caribbean Basin, Central 
Africa, and South Japan [9]. 
2. HTLV-1 Replication Cycle and Virus Particle Assembly 
Despite the association of HTLV-1 with cancer and its significant impact on human health, many of 
the details regarding HTLV-1 replication, assembly and many fundamental aspects of virus particle 
structure  remain  poorly  understood.  The  steps  involved  in  the  replication  of  retroviruses  such  as 
HTLV-1  (a  deltaretrovirus)  include  virus  entry,  reverse  transcription  of  the  viral  RNA  to  DNA, 
integration of the viral DNA, transcription of the viral DNA, packaging of the viral RNA, particle 
assembly and virus particle release. Important  early steps in the virus assembly pathway that are 
poorly understood for HTLV-1 (as well as all retroviruses) include genome recognition (Gag-RNA 
interactions) as well as Gag-Gag and Gag-cellular protein interactions.  
Many retroviruses, including HTLV-1, initiate particle assembly in the cytosol but this does not 
become apparent until the accumulation of viral proteins and nucleic acid at the plasma membrane. 
Assembly of virus particles and budding at the plasma membrane are readily visualized by electron 
microscopy.  Gag  proteins  associate  with  raft  microdomains  of  the  inner  leaflet  of  the  plasma 
membrane [10,11]. The Gag polyprotein is a primary driving force for assembly and budding. The 
trafficking of Gag proteins to the cell membrane and stable membrane association involve a bipartite 
membrane  binding  signal  consisting  of  the  fatty  acid  myristate,  added  cotranslationally  to  the  N 
terminus of Gag in concert with a patch of basic residues within the matrix (MA) domain [12,13]. 
Little  is  known  regarding  details  of  how  HTLV-1  Gag-Gag  and  Gag-membrane  interactions  are 
orchestrated in cells as well as the fundamental aspects for what determines Gag stoichiometry in 
particles and particle size. 
3. Gag-Gag Interactions and Membrane Targeting  
The difficulties in propagating HTLV-1 in cell culture precluded the thorough characterization of 
HTLV-1 replication, including the aspects that relate to Gag trafficking and assembly. Nonetheless, Viruses 2011, 3                         
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recent  progress  has  been  made  using  both  molecular  biological  and  biophysical  techniques.  
Post-translation, Gag is trafficked from the cytoplasm to the inner leaflet of the plasma membrane. 
Gag-Gag interactions may occur either in the cytoplasm or after arrival at the plasma membrane, 
eventually leading to the assembly and budding of the immature virions.  
Due to the paucity of knowledge concerning HTLV-1 Gag cytoplasmic behavior, it is helpful to use 
comparative approaches to assist in gaining greater insights into HTLV-1. The obvious candidate for 
such  comparative  analysis  is  HIV-1  Gag,  whose  trafficking  and  assembly  pathways  have  been 
extensively  studied  (reviewed  in  [14]).  In  addition,  HIV-1  is  also  a  human  retrovirus  that,  like  
HTLV-1,  infects  CD4
+  T-cells.  A  relevant  HIV-1  Gag  assembly  model  is  the  oligomerization-
dependent myristoyl-switch model, in which Gag interactions in the cytoplasm trigger the exposure of 
a hydrophobic myristic acid moiety which targets Gag to the inner-leaflet of the plasma membrane 
[15–17]. A  consequence of this model  is that  HIV-1 Gag multimers would be depleted  from the 
cytoplasm, as any Gag species larger than a monomer would exhibit a membrane-targeting signal. 
Biochemical experiments which support this model have been reported  [18]. In vitro  biochemical 
methods have been used to investigate HTLV-1 Gag-Gag and HTLV-1 matrix interactions in both the 
cytoplasmic  and  membrane  fractions  of  cells,  and  evidence  was  found  for  Gag-Gag  interactions 
occurring exclusively at the membrane [19]. Complimentary evidence was found by others using a 
variety of in vitro methods to investigate the self-associative behavior of the HTLV-1 Gag capsid 
domain. While HIV-1 capsid proteins were found to readily dimerize in solution, HTLV-1 capsid 
proteins exhibited no observable interactions up to millimolar concentrations [20]. These observations 
suggest that HTLV-1 Gag, unlike HIV-1 Gag, may initiate assembly at the inner-leaflet of the plasma 
membrane. Further detailed studies are needed to access this intriguing possibility. 
Another model system which provides additional information concerning the possible initiation of 
Gag assembly in the cytoplasm is a Gag protein with a point mutation (mutation of the glycine residue 
near the N-terminus of Gag to alanine) that eliminates the post-translational addition of the myristic 
acid moiety. This G2A Gag species has been shown, for both HIV-1 [21,22] and HTLV-1 [19,23], to 
be lacking myristoylation and is membrane-binding deficient. The expected model for G2A mutants 
differs from wild-type Gag in that G2A Gag multimers are deficient in membrane-binding and thus are 
not depleted from the cytoplasm. Thus, G2A Gag is expected to reach higher concentrations and 
higher-order complexation in the cytoplasm when compared with wild-type Gag. Once again, this 
model has been supported by biochemical observations with the HIV-1 G2A Gag mutant [18]. 
It should be noted that there is ample evidence for HIV-1 Gag that myristoyl moiety exposure and 
subsequent membrane binding is not solely due to Gag homo-interactions. A number of studies have 
provided strong evidence that other factors also play a role in HIV-1 Gag membrane targeting. The 
lipid phosphatidylinositol (PI) 4,5-bisphosphate [PI(4,5)P2] has been shown in multiple studies to 
interact with the Gag matrix domain that favor exposure of the myristoyl moiety [24-27]. Other studies 
have implicated both host factors, such as calmodulin [28], and the cell environment, (pH [29]), as 
playing a role in myristate exposure. Such additional factors are likely to be involved in HTLV-1 Gag 
assembly as well. Recent studies have demonstrated that HTLV-1 Gag interacts with the inner loop of 
membrane-bound tetraspanins [30,31].  
It is generally accepted that Gag-membrane interactions are not solely dependent on exposure of the 
myristic acid moiety but are also dependent on electrostatic interactions between basic residues of the Viruses 2011, 3                         
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matrix domain and the negatively charged phospholipid head groups of the membrane [32,33]. In 
addition, the viral genome has been shown to play a structural role in Gag-Gag interactions for HIV-1, 
and so may play a role in the initiation of Gag-Gag interactions either in the cytoplasm or at the 
membrane for HTLV-1 [18,34–36].  
4. Fluorescence-Based Characterization of Gag Interactions in Living Cells 
A key drawback for many of the methods used to investigate cytoplasmic HTLV-1 and HIV-1 Gag 
behavior is that the techniques must disrupt the cellular environment in order to isolate Gag molecules 
for investigation. This is problematic because the isolation of Gag molecules necessitates the removal 
of  cellular  host  factors  and  machinery  that  might  play  a  prominent  role  in  Gag  trafficking.  For 
example, it is known the HIV-1 Gag interacts with an array of host factors on its pathway to assembly 
(reviewed in [14,37,38]). For this reason, it is vital to develop minimally-invasive techniques which 
are  capable  of  investigating  HTLV-1  Gag  cytoplasmic  behavior.  Model  systems  that  have  used  
codon-optimized  gag  genes  and  carboxy-terminal  tags  such  as  GFP,  have  provided  new  tractable 
approaches for studying Gag trafficking and homo-interactions as well as membrane interactions. The 
impact of such perturbations on Gag trafficking needs further investigation. 
To date, the most promising advances for studying retroviral Gag trafficking and assembly in vivo 
involve fluorescence-based techniques. These techniques typically rely on Gag constructs which are 
tagged  with  one  of  a  number  of  fluorescent  proteins.  Fluorescence-based  assays  are  minimally 
invasive,  as  labeled  Gag  proteins  can  be  monitored  in  living  cells  which  are  incubated  on  the 
microscope  stage.  The  lone  perturbation  to  the  Gag  expression  system  is  the  introduction  of  the 
fluorescent tag. The introduction of a tag to the protein could have unforeseen consequences on the 
Gag trafficking pathway. While this is a legitimate concern, it has been shown previously that HIV-1 
Gag  tagged  at  the  C-terminus  with  yellow  fluorescent  protein  (EYFP)  and  untagged  wild-type 
constructs  are  incorporated  non-preferentially  into  virus-like  particles  (VLPs)  [39].  VLPs  are  
non-infectious analogues of infectious virions which contain the structural elements of the virus, but 
lack viral components which are required for viral propagation. They have been shown to  closely 
mimic the structure and morphology of infectious virions (reviewed by [40]). In addition, it has been 
shown that HIV-1 Gag, C-terminally labeled with GFP, is incorporated into infectious virions when 
coexpressed with wild-type Gag [41]. Finally, a Gag construct with GFP inserted between the matrix 
and capsid domains of HIV-1 Gag has been shown to produce infectious viral particles with similar 
single-round  infectivity  to  that  of  wild-type  particles  [42,43].  These  observations  support  the 
hypothesis that the fluorescence tag may have minimal impact on Gag trafficking and assembly.  
One  example  of  a  fluorescence-based  technique  relevant  to  HTLV-1  Gag  behavior  is  imaging 
localization of Gag molecules in fixed cells. Studies have revealed important insights into the role of 
the  late  domain  in  viral  assembly  [44–46].  Fluorescence  localization  also  provided  evidence  that 
HTLV-1  Gag  preferentially  targets  tetraspanin-enriched  microdomains  associated  with  the  plasma 
membrane for assembly [30,31], avoiding interactions with intracellular membranes [23]. 
Another promising technique for the in vivo study of retroviral Gag trafficking and assembly is 
fluorescence resonance energy transfer (FRET) (reviewed in [47,48]) (Figure 1). This technique relies 
on energy transfer between two different fluorophores (an energy donor and an energy acceptor) to Viruses 2011, 3                         
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probe intra- and intermolecular interactions. The efficiency of energy transfer depends on the inverse 
sixth  power  of  the  distance  between  the  fluorophores,  and  is  used  to  monitor  interactions  at  the 
nanometer scale. FRET has been used to probe Gag-Gag interactions for HIV-1 [49,50] and RSV [51], 
as well as HIV-1 Gag-nucleic acid interactions [36] and HTLV-1 NC-nucleic acid interactions [52]. 
The  fluorescence  techniques  described  so  far  provide  a  suitable  technology  platform  for  the 
investigation  of  retroviral  Gag  trafficking  and  assembly  in  living  cells.  In  recent  years,  the 
development of a suite of biophysical fluorescence techniques has further augmented the analytical 
power of fluorescence-based investigations. In particular, total internal reflection fluorescence (TIRF) 
(reviewed by [53]) and two-photon fluorescence fluctuation spectroscopy (FFS) (reviewed by [54,55]) 
have been used to reveal intriguing insights into Gag behavior. 
Figure 1. Fluorescence resonance energy transfer (FRET). FRET is used for monitoring 
intra- and inter-molecular interactions occurring on the nanometer scale. The transfer of 
excitation  energy  from  a  ―donor‖  fluorophore (Gag-CFP)  to an ―acceptor‘ fluorophore 
(Gag-YFP) is monitored. The donor molecule is excited with light at a wavelength that 
does not excite the acceptor molecule. At distances between donor and acceptor greater 
than  approximately  5  nm,  the  excited  donor  molecule  emits  fluorescence  at  its 
characteristic  wavelength.  At  distances  below  5  nm,  the  excited  donor  molecule  can 
transfer energy to the acceptor molecule, resulting in the acceptor fluorescing at a longer 
wavelength. In this example, a decrease in Gag-CFP signal, with a corresponding increase 
in Gag-YFP signal would indicate Gag-Gag interactions. 
 
 
In TIRF microscopy, excitation light is transmitted to the cover slip-sample interface at an angle 
greater than the critical angle (Figure 2). This results in the incident light being totally reflected at the 
interface. Despite the total reflection of the excitation light, an evanescent field is established that 
penetrates into the sample to a depth of about 100 nm. In retroviral Gag in vivo studies, this excitation 
penetration depth corresponds to the cell plasma membrane and the cytoplasm-membrane interface. 
The  limited  penetration  of  the  excitation  light  only  excites  fluorophores  at  or  proximal  to  the 
membrane, and therefore greatly increases sensitivity and signal to noise due to the elimination of 
cytoplasmic background fluorescence. Thus TIRF microscopy is ideal for studying the steps of Gag 
trafficking and assembly which occur at the plasma membrane.  Viruses 2011, 3                         
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Figure 2. Total Internal Reflection Fluorescence (TIRF) microscopy. In objective-based 
TIRF microscopy, the excitation laser is positioned to enter at the edge of the back aperture 
of a high-NA objective (NA ≥ 1.45). The beam emerges from the objective at an angle, 
which  is  greater  than  the  critical  angle  of  the  cover-slip/sample  interface.  Thus,  the 
excitation  beam  is  totally  reflected  back  down  through  the  objective.  Despite  this  
total reflection, an evanescent, or near-field, wave penetrates approximately 100 nm into 
the  sample  (inset).  This  results  in  a  spatially  confined  excitation  region  at  the  
cover-slip/sample interface. In cellular applications, the near-field light would only excite 
fluorophores at the bottom membrane, and in a small region of the cytoplasm proximal  
to the membrane. Therefore, this technique is ideal for probing proteins that interact with 
the membrane. 
 
 
To  date,  TIRF  studies  have  focused  on  HIV-1  Gag  behavior.  Recent  studies  monitored  the 
dynamics  of  VLP  assembly  at  the  membrane,  determining  the  timescale  from  the  beginning  of 
detectable  assembly  at  the  membrane  (~10  Gag  molecules)  to  eventual  budding.  Jouvenet  et  al. 
determined that 5–6 minutes passed from the first detection of an assembling VLP to a steady-state 
assumed to be the assembly endpoint [56]. In another study, Ivanchenko et al. demonstrated that the 
steady-state observed in the previous study was likely the budding of the viral particle and is followed 
by VLP release [57]. They found that the average timescale for HIV-1 VLP assembly, budding, and 
release was closer to 25 minutes. In a more recent study, the role that the viral genome plays in Gag 
assembly at the membrane was investigated [35]. It was found that RNA is detectable at a membrane 
assembly site before Gag is present at detectable levels, supporting the idea that viral RNA plays a 
structural role in VLP assembly. Finally, a recent study examined the role of the cellular ESCRT 
machinery in HIV-1 budding and release (For the role of ESCRT complexes in HIV-1 budding and 
release, see [41]). The study focused on the ESCRT-associated protein VPS4A, which is thought to 
play a role in membrane scission, and thus particle release. The study found that VPS4A proteins 
indeed arrive at sites of fully-assembled VLPs, promoting VLP membrane scission and release on a 
~35 s timescale [58].  Viruses 2011, 3                         
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Two-photon fluorescence fluctuation spectroscopy (FFS) is a quantitative method which is ideally 
suited to explore protein interactions in living cells, and has been used to study RSV  [51], HIV-1 
[39,59], and HTLV-1 [59,60] Gag behavior (Figure 3). In two-photon excitation, a pulsed infrared 
laser,  approximately  double  the  one-photon  excitation  wavelength  of  the  fluorescent  protein,  is 
focused within the sample of interest. If the laser intensity is high enough at the focal position, the 
fluorophore  can  be  excited  by  the  near  simultaneous  absorption  of  two  infrared  photons,  each 
supplying half of the total excitation energy [61]. Two-photon excitation is restricted to the close 
proximity of the laser focus, because it is only in this region that the intensity is high enough to 
support efficient two-photon absorption. Knowledge of the optics allows the calculation of a focal 
volume ([62]), which provides a convenient measure of the effective volume observed by two-photon 
excitation. This results in fluorophore excitation which is limited to a spatially defined volume on the 
order  of  less  than  one  femtoliter  (10
−15  L,  ~1/1000th  of  a  cell‘s  volume).  This  spatially  defined 
excitation method has distinct advantages over one-photon excitation: it minimizes photodamage to 
the small two-photon excitation volume and thus minimizes photobleaching of biological samples. In 
addition, it avoids potential contamination of single molecule fluorescence from Raman scatter of the 
solvent [61,63]. 
Figure 3. Fluorescence Fluctuation Spectroscopy (FFS). FFS monitors the fluorescence of 
single  molecules  moving  through  a  laser  excitation  region.  In  FFS  using  two-photon 
excitation  (2PE)  a  pulsed  infrared  laser  is  used  to  create  a  small  excitation  region 
(~1/1000
th the volume of a cell) in the sample. The fluorophore is only excited in the focal 
region of the beam, as explained in the text. A single Gag-YFP molecule which either 
diffuses  or  is  transported  through  the  focal  volume  (inset)  causes  a  burst  in  detected 
fluorescent intensity. By monitoring the characteristic timescale, amplitude, and frequency 
of the fluorescent fluctuations caused by single molecules moving through the focus, one 
can  obtain  information  relating  to  protein  mobility  (duration  of  fluctuations),  protein 
stoichiometry (amplitude of fluctuations), and concentration (frequency of fluctuations). 
 
 
FFS monitors the fluorescence fluctuations caused by single-labeled proteins that migrate in and 
out of the diffraction-limited two-photon observation volume. Analysis of the fluctuations provides Viruses 2011, 3                         
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information on the concentration, mobility, and brightness of fluorescent proteins  [62,64,65]. The 
most  common  application  of  FFS  analysis  is  the  investigation  of  protein  diffusion  and  transport 
through  investigation  of  fluorescence  burst  duration,  or  correlation  analysis.  FFS  restricted  to 
correlation analysis is also known as fluorescence correlation spectroscopy (FCS), and was introduced 
by Webb and coworkers [66,67]. Determination of protein stoichiometry through brightness analysis, 
or investigation of fluorescence fluctuation amplitude, is another analysis technique used in FFS. This 
brightness-based  method  uses  the  photon  counting  histogram  (PCH)  to  determine  the  number  of 
molecules  in  the  observation  volume  and  their  brightness  from  the  shape  of  the  photon  count 
distribution [68]. Brightness is a measure of the average fluorescence intensity of a single molecule 
passing through the observation volume, and is reported in counts per second per molecule (cpsm). 
Access to the brightness of fluorescent proteins provides a unique way to determine the stoichiometry 
of proteins in cells. A monomer of Gag, labeled with a fluorescent protein, has a certain characteristic 
brightness,  based  on  the  nature  of  the  fluorophore.  A  dimer  of  labeled  Gag  molecules  has  two, 
identical fluorophores, and thus would be twice as bright, with higher-order complexes being higher 
integer multiples of monomer brightness. Brightness has been shown to be a robust technique for the 
determination of protein stoichiometry over a wide range of oligomerization levels [39,60,64]. 
The  single  molecule  sensitivity  and  high  spatial-temporal  resolution  of  FFS  allows  for  the 
comprehensive study of the Gag trafficking and assembly pathway. This is evident in recent FFS 
studies used to characterize RSV, HIV-1, and HTLV-1 Gag behavior. 
5. Cryo-Electron Microscopy (Cryo-EM) and Cryo-Electron Tomography (Cryo-ET) of 
Retroviral Particles 
The  cryo-EM  and  three-dimensional  (3D)  reconstruction  technique  is  a  powerful  tool  in 
determining the structure of a broad spectrum of samples ranging from 200 kDa macromolecules to 
large cellular organelles and small cells in their native frozen-hydrated state [69–71]. Cryo-EM allows 
the study of structures of specimens that do not form well-diffracted crystals or molecular complexes 
that are too large for NMR spectroscopy. Interesting molecular activities can be arrested when the 
specimen  is  frozen  in  liquid  ethane  (~−180  C)  (Figure  4A)  and  molecular  structural  details  are 
preserved with minimal artifacts. With the employment of the field emission gun electron microscope 
and  advancement  of  robust  computational  software,  the  resolution  of  a  cryo-EM  map  for  
specimens such as icosahedral viruses and symmetric protein complexes is achievable to near atomic 
level [72–76]. Given these advances, cryo-EM has become an indispensable tool in modern structural 
biology [77].  
Because  retroviruses  have  heterogeneous  morphology,  structural  investigation  of  retrovirus 
particles  has  traditionally  relied  on  electron  tomography  (ET)  [70,78].  ET  studies  the  structure  
of  one-of-a-kind  objects,  such  as  cellular  organelles  [79–81],  retroviruses  [82–85]  and  small  
cells [86–88]. Shown in Figure 4B–C, ET involves recording images of the same specimen area at 
various tilt angles in the microscope (within 70). The recorded tilt series are then translationally and 
rotationally  aligned  to  be  brought  into  register  for  computation  of  a  3D  reconstruction  map  
(Figure 4D) [89]. The alignment is accomplished by calculating either the cross-correlation of images 
at close tilt angles [90–92] or the shift vectors and rotation using colloidal gold particles mixed with Viruses 2011, 3                         
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the specimen [93–95]. The 3D reconstruction map is then calculated using a weighted back projection 
method [96] or algebraic iterative techniques [97,98]. Due to the limitation of the tilt angles of the 
specimen  stage  in  the  microscope,  the  tomography  data  has  missing  regions  in  space.  The 
incompleteness  of  the  data  and  high  electron  radiation  damage  of  the  frozen  specimen  limit  the 
attainable resolution of the ET and cryo-ET reconstruction maps to 4–6 nm [99,100].  
Figure 4. Cyro-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET). 
(A) Preparation of frozen hydrated cryo-EM grid. A small aliquot (~3 µL) of specimen is 
added to a perforated carbon TEM grid. The grid is blotted by a filter paper and is quickly 
plunged into liquid ethane. The water in the specimen forms vitreous ice that is suspended 
across the holes of the perforated carbon film. The inset panel shows virus particles (green 
hexagons) embedded in the vitreous ice (grey). (B) Position of the TEM grid relative to the 
electron microscope column. The specimen holder in the microscope is perpendicular to 
the electron beam. The TEM grid can be rotated between −70° to 70° (α angle) around the 
tilt axis of the specimen holder. (C) A diagram showing a set of images of three virus 
particles (green) recorded at various α tilt angles (inset). ―p‖ represents the position of the 
specimen holder tilt axis in each image. (D) Three-dimensional (3D) reconstruction map 
and an extracted model of one virus particle. The reconstruction map is represented as a set 
of two-dimensional slices, which cut through the 3D map of the virus particles (blue). The 
3D  model  of  any  virion  (inset)  can  be  extracted  from  the  reconstruction  map  for 
further analysis. 
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When  compared  to  x-ray  crystallography  and  NMR  spectroscopy,  cryo-EM  and  cryo-ET 
reconstruction methods provide reconstruction maps at lower resolution. The sub-tomogram averaging 
method [101,102] is used for improving the resolution of a sub-volume in the reconstruction map that 
allows fitting of the atomic structure of the protein components into the boundary of the electron 
densities of the macromolecular complexes [82,85,103]. Understanding molecular organization of the 
proteins helps to derive the proteins boundary and molecular interface, so the key amino acid residues 
which are essential to the virus assembly and function can be identified. The sub-tomogram averaging 
technique  has  been  utilized  in  many  studies  that  determine  the  Gag-Gag  assembly  in  immature 
retrovirus particles [82,104–106]. 
Extensive cryo-ET studies on retroviral assembly and maturation have been focused on immature 
and mature virus-like particles (VLP) of HIV-1 [82,83,104,105,107], Rous sarcoma virus (RSV, an 
alpharetrovirus) [84,108,109] and Mason-Pfizer monkey virus (MPMV, a betaretrovirus) [106]. In 
HIV-1  immature  particles,  it  was  found  that  the  capsid  proteins  (CA)  are  arranged  in  a  single, 
continuous but incomplete hexameric lattice with irregular defects and about 8 nm spacing between 
the C-terminal domains of CA [82,107]. Similar Gag-Gag arrangements in immature particles were 
also demonstrated in RSV and MPMV through cryo-ET reconstruction and sub-tomogram averaging 
methods, suggesting the molecular organization of Gag are conserved among several retrovirus genera 
[106]. Although there is very little sequence similarity, the tertiary structures of the matrix (MA), CA 
and nucleocapsid (NC) domains of Gag are conserved among the retroviruses [110]. The conserved 
Gag  lattice  found  in  three  genera  of  retroviruses  implies  that  intermolecular  interactions  of  these 
domains in Gag are critical during assembly of the retrovirus immature particles.  
Understanding the structure of mature retroviruses includes investigating the organization of the 
cores that encapsulate the viral genome and the arrangement of the viral envelope proteins using  
cryo-EM and cryo-ET reconstruction methods. During retrovirus maturation, proteolytic cleavage of 
Gag leads to rearrangement of CA and formation of the retroviral core. The nucleocapsid domain of 
Gag and the viral RNA are condensed into a ribonucleoprotein complex which is encapsulated inside 
the core. The matrix domain of Gag remains associated with the viral membrane. The cone-shaped 
capsid is composed of pentameric and hexameric arrangements of CA subunits. In vitro, the HIV-1 
CA spontaneously assembles into helical tubular structure and cone-shaped particles that resemble 
authentic  viral  capsids  [111].  The  helical  tubular  structure  of  CA  allows  determination  of  the 
hexameric  arrangement  of  CA  at  high  resolution.  Fitting  the  atomic  structures  of  CA  into  the 
reconstruction map demonstrated that the N-terminal domain of CA forms hexameric rings and the  
C-terminal dimerization domains connect the ring-structures together. A more recent study [112] using 
a 16 Å resolution cryo-EM reconstruction map of a tubular-assembled HIV-1 CA in conjunction with 
an atomic-resolution NMR structure of the C-terminal domain dimer of CA reviewed critical amino 
acids residues at the CA protein interface. Understanding of the pentameric arrangements of CA is 
derived from cryo-EM reconstruction of  in vitro-assembled capsids of RSV that have icosahedral 
symmetry [109]. This study suggested that electrostatic interactions govern the differential assembly 
of pentamers and hexamers in retrovirus cores. 
Cryo-ET reconstruction and sub-tomogram averaging methods were also used to study the trimeric 
HIV-1 envelope protein spikes and its interaction with neutralizing antibodies and cell surface receptor 
CD4  [85,103].  Each  envelope  protein  spike  is  composed  of  three  copies  of  a  heterodimer  of Viruses 2011, 3                         
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glycoproteins gp41 and gp120. Molecular models for the native HIV-1 gp120 trimers in unbound 
particles and the CD4-bound states derived from the study suggested that binding of CD4 introduces a 
major reorganization of the gp41 and gp120 monomers in HIV-1 spike proteins that leads to closer 
contact between the viral and target cell membranes [85].  
The ultimate goal of studying the structures of immature and mature retroviral particles is to better 
understand the molecular mechanisms that drive virus assembly, budding, maturation and infection. 
Cryo-ET studies on the HIV-1 budding sites in HeLa and MT-4 cells [113] implicate that budding is 
initiated by Gag assembly and is completed in an ESCRT-dependent manner before the Gag sphere is 
complete. In a follow-up study [114], the structure of the Gag lattice of VLPs at the budding site in 
human cells was found to be indistinguishable from those of released immature VLPs, suggesting little 
structural rearrangement of Gag proteins occur after virus budding and before proteolytic cleavage. 
Another  study  spearheaded  investigation  of  the  virological  synapse  presented  in  HTLV-1 
immortalized cells MS9 [115] using ET of plastic thin sections combined with immunostaining of the 
viral proteins. The study illustrated in 3D the synaptic clefts that have HTLV-1 particles and are 
surrounded by the tightly apposed plasma membranes of two cells. The size of the synaptic clefts in 
the reconstruction map suggested that HTLV-1 virions can contact the recipient cell membrane before 
detaching from the infected cell. 
Cryo-EM, ET and cryo-ET studies on retroviral VLPs (especially HIV-1), in conjunction with the 
x-ray crystallography and NMR studies of individual domains of Gag proteins  [17,116–124] have 
provided vast structural information on viral structural protein organization in immature and mature 
particles  of  various  retroviruses  and  retroviral  VLPs  in  the  context  of  cellular  environment. 
Application  of  these  techniques  to  HTLV-1  is  still  very  limited  [60,115,125].  We  expect  to  see 
exciting progress in this field in the near future. 
6. FFS and Cryo-EM Characterization of HTLV-1 and HIV-1 Gag 
The first application of FFS to a retroviral Gag system was the use of FRET and FFS to investigate 
both RSV Gag-Gag interactions, and cytoplasmic Gag mobility [51]. FRET was used to demonstrate 
that Gag-Gag interactions were occurring both at the membrane and in the cytoplasm. FFS analysis 
investigated the mobility and brightness of cytoplasmic Gag, and found that Gag exhibited mobility 
indicative  of  large  protein  complexes,  while  the  brightness  indicated  that  the  Gag  stoichiometry  
in  these  complexes  was  low,  and  thus  it  was  likely  that  unlabeled  host  proteins  were  present  
in the complexes. 
FFS was subsequently applied to the analysis of Gag stoichiometry and size by brightness and FCS 
analysis for both HIV-1 [39,126] and HTLV-1 [60] virus-like particles. It was found that HIV-1 Gag 
stoichiometry ranged from 750 to 4000 copies of Gag per VLP, with an average VLP diameter of 130 
nm. While the Gag copy number per VLP varied, the size remained constant. This led to the proposed 
hypothesis  that  Gag  formed  an  incomplete  shell  in  VLPs.  This  hypothesis  was  confirmed 
independently by cryo-ET. The average size of HIV-1 particles reported by FFS and cryo-EM agree 
with each other. The stoichiometry derived from cryo-EM studies of both immature and mature HIV-1 
particles overlaps with the stoichiometry range reported by FFS. [82,83,111].  Viruses 2011, 3                         
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Recently a study by Grigsby et al. applied both FFS and Cryo-EM towards the study of HTLV-1 
particles [60]. This work provided a first glimpse into the structure, stoichiometry and size of HTLV-1 
viral particles. A key component of this study was the development of a codon-optimized HTLV-1 
Gag-EYFP construct which overcame the challenge of HTLV-1‘s low expression levels in cell culture. 
In this study, Cryo-EM was used to investigate the size and morphology of HTLV-1 VLPs, while FFS 
was  implemented  for  both  size  and  Gag  stoichiometry  information.  It  was  found  that  HTLV-1  
virus-like  particles  were  significantly  smaller  than  HIV-1  VLPs,  the  particle  diameters  found  
were 71 ± 20 and 75 ± 4 nm by Cryo-EM and FFS respectively. This is a little more than half the 
particle diameters found by both FFS and Cryo-EM for HIV-1 viral particles. The smaller size found 
for the particles was complimented with a decrease in the average HTLV-1 Gag stoichiometry of 
VLPs,  relative  to  HIV-1  particles.  The  average  Gag  stoichiometry  found  for  HTLV-1  VLPs  was  
~500 copies per particle. This number supports the hypothesis that, like HIV-1 VLPs, there is a partial 
Gag shell in the average HTLV-1 VLP, as a fully closed shell would be expected to have a Gag 
stoichiometry of ~1300.  
The  VLP  studies  confirmed  FFS  as  a  technique  that  could  independently  verify  size  and 
stoichiometry information obtained by Cryo-EM. In addition, the sample preparation of VLPs for FFS 
analysis is extremely simple, as VLPs can be obtained directly from the culture supernatant, without 
the need for concentration, purification, and careful preparation required by Cryo-EM. While FFS 
cannot  match  the  kind  of  structural  information  available  to  Cryo-EM,  its  ability  to  perform 
quantitative analysis in living cells renders it a powerful tool in the study of HTLV-1. 
A more recent FFS study of Gag trafficking and assembly investigated the extent of both HIV-1 
and HTLV-1 Gag oligomerization in the cytoplasm [59]. The average cytoplasmic stoichiometry of 
Gag versus cellular expression level was found for both the wild-type species and the respective G2A 
mutants. It was found that, for both HIV-1 and HTLV-1 wild-type species, Gag was predominantly 
monomeric over the full range of measured cytoplasmic concentrations (10 nM to ~600 nM). The data 
for HIV-1 wild-type Gag agrees well with a recent study, in which the isolated, cytoplasmic fraction of 
HIV-1 Gag was found to be dominated by Gag monomers [18]. A unique aspect of FFS is its ability to 
explore the cytoplasmic oligomerization-state of Gag in vivo, on a cell-by-cell basis, as a function of 
the cellular expression level.  
Investigation of cytoplasmic G2A mutants for both HIV-1 and HTLV-1 by FFS revealed intriguing 
differences  in  the  behavior  of  the  two  Gag  species.  HIV-1  G2A  Gag  exhibited  a  concentration-
dependent increase in its average oligomerization (from monomers to greater than octamers) over a 
concentration range from 10 nM to ~6 μM. Again, these findings are in agreement with a recent study 
on  HIV-1  [18],  although  it  has  also  been  reported  that  myristoylation  is  required  for  HIV-1 
multimerization  [127].  This  discrepancy  may  indicate  that  Gag-Gag  interactions  occurring  in  the 
cytoplasm are relatively weak. 
This  data  supports  the  model  for  HIV-1  Gag  assembly  and  membrane  targeting  where  Gag 
interactions  in  the  cytoplasm  lead  directly  to  myristate  exposure  and  membrane  targeting.  For  
wild-type, Gag oligomers are depleted from the cytoplasm, and thus the dominant cytoplasmic Gag 
species is the monomer. In addition, depletion of Gag from the cytoplasm caused by targeting to the 
membrane places an upper limit on the cytoplasmic concentration of Gag. G2A mutants lack the 
myristoyl moiety which promotes Gag membrane association. This results in a Gag species that is Viruses 2011, 3                         
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strictly cytoplasmic. G2A Gag oligomers do not have a sufficient membrane-binding signal and thus 
remain in the cytoplasm. As a consequence, G2A Gag accumulates to much higher concentrations in 
the cytoplasm when compared to wildtype, which favors the formation of oligomerized Gag species. 
Surprisingly, HTLV-1 G2A Gag exhibited no increase in oligomeric state, despite reaching the 
same elevated cytoplasmic concentrations found for HIV-1. A previous study by Rayne and coworkers 
corroborates this evidence as they found no evidence for G2A Gag complexes in the cytoplasmic 
fraction of lysed cells [19]. This difference in the behavior of the two viral Gag species suggests that 
the  HTLV-1  Gag  trafficking  pathway  might  differ  from  HIV-1.  It  was  proposed  by  Rayne  and 
coworkers  that  myristoylation  is  required  for  HTLV-1  Gag  multimerization.  The  FFS  data 
corroborates the evidence for a possible difference in the location of the onset of Gag-Gag interactions 
for HIV-1 and HTLV-1, respectively. 
The FFS study which probed HTLV-1 and HIV-1 Gag-Gag interactions in the cytoplasm also 
discovered some interesting information concerning the behavior of membrane-bound Gag for both 
species [59]. To ensure that cytoplasmic fluorescence measurements were not altered by fluorescence 
from Gag complexes at the membrane, the study made use of the recently developed method of z-scan 
FFS [128–130]. In z-scan FFS, the two-photon excitation volume is scanned through the cell along the 
z-axis, entering the cell through the membrane-medium interface, and exiting through the membrane-
coverslip  interface.  This  z-scan  yields  a  fluorescent  intensity  trace  which  contains  information 
concerning both the geometry of the cell and the size of the focal volume [128]. In cells expressing 
Gag, there are populations of Gag molecules heterogeneously distributed both at the membrane and in 
the cytoplasm. At locations where there is a population of Gag at the membrane, the z-scan fluorescent 
intensity  profile  identifies  the  presence  of  membrane-bound  Gag.  The  z-scan  FFS  profile  can  
be  analyzed  to  determine  the  nature  of  the  Gag  membrane-bound  fraction  at  precise  positions  
within a cell. 
The z-scan FFS analysis applied to the HTLV-1 and HIV-1 Gag systems found some interesting 
aspects in the behavior of membrane-bound Gag species for both viruses. It was found that, for both 
viruses, a significant portion of the surface of the plasma membrane was covered by non-punctate Gag 
with a low degree of oligomerization. Thus, Gag is not present at the membrane solely as discrete 
puncta, but also as a kind of dynamic ―sheet‖ of low copy number Gag complexes. Time-resolved  
z-scan  measurements  found  that  the  presence  of  membrane-bound  HIV-1  and  HTLV-1  Gag  at 
measured  positions  was  long-lived;  the  persistence  of  the  membrane-bound  fraction  exceeded  the 
duration of the experiments, which monitored the membrane for 20 minutes or more. The apparent 
concentration of Gag at these positions was dynamic; membrane intensity fluctuations implied mobile, 
low order Gag complexes which change the local surface density of Gag at the membrane with time. 
7. Emerging Fluorescent Methodologies 
The application of biophysical fluorescence approaches to the study of retroviral Gag trafficking 
and assembly has provided novel information concerning not only HTLV-1 Gag behavior, but also for 
the  comparatively  well-studied  HIV-1  Gag  species.  Quantitative,  time-resolved  analysis  of  Gag 
behavior  at  the  membrane  has  been  achieved  with  near  single  molecule  resolution  using  TIRF 
microscopy [35,56–58]. FFS has been demonstrated to have unparalleled sensitivity for quantifying Viruses 2011, 3                         
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retroviral  Gag  behavior,  from  the  cytoplasmic  behavior  of  mostly  monomeric  Gag  [51,59]  to  the 
stoichiometry and size of retroviral VLPs [39,60].  
There are a number of recently developed biophysical fluorescence techniques which hold promise 
for application to the study of HTLV-1 Gag trafficking and assembly. Perhaps the most exciting 
advances  in  fluorescence  microscopy  in  recent  years  are  sub-diffraction  fluorescence  imaging 
techniques (reviewed by [131]). In conventional fluorescence microscopy, the optical resolution of the 
instrument is diffraction limited to about half the wavelength of the excitation light. For instance, for 
excitation light with a wavelength of 500 nm, the highest achievable resolution of a fluorescence 
experiment would be 200 nm. In other words, if two fluorescent proteins are separated by less than 
200 nm, they are indistinguishable from one another in conventional light microscopy. As a single 
virion of HTLV-1 or HIV-1 is actually smaller than this resolution limit, structural or morphological 
features of the virion are unobservable by conventional fluorescence microscopy. In recent years, 
however, an array of techniques have been developed that take advantage of both the unique properties 
of fluorophores and the physics of light to accurately obtain resolution down to tens of nanometers. As 
a whole, these techniques are referred to as super-resolution microscopy (reviewed by [131,132]). 
One category of super-resolution spectroscopy uses the idea of reversible switching of fluorophores 
between an ‗on‘ and ‗off‘ state in order to limit the fluorescence to a sub-diffraction limited volume. 
The most common example is stimulated emission depletion spectroscopy (STED) [133,134]. In this 
technique,  two  laser  beams  are  used.  One  laser  is  the  excitation  laser,  which  is  at  the  excitation 
wavelength of the fluorophore. The second beam is used for stimulated emission depletion; it is at a 
wavelength which causes stimulated emission of the fluorophores at the wavelength of the depletion 
laser. This stimulated emission forces the fluorophores back to the ground state. The excitation is 
focused  to  a  diffraction  limited  spot,  while  the  depletion  laser  is  focused  to  a  diffraction  limited 
―donut‖ at the same position of the excitation spot. The ―donut hole‖ of the depletion focus, which is 
much smaller than the excitation spot, is the only position at which molecules fluoresce, because it is 
the only region at which the excitation beam is not overlapped by the depletion beam.  
A  second  category  of  super-resolution  involves  the  photoswitching  or  photoactivation  of 
fluorophores,  such  that  only  a  sparse  few  are  fluorescing  at  any  given  time.  If  the  fluorescing 
molecules are positioned such that there is only one fluorophore located within a diffraction-limited 
spot, their relative positions can be found with nanometer-scale resolution. In the next phase of the 
experiment,  a  different  subset  of  fluorophores  is  ―turned  on‖  either  through  a  photoswitching  or 
photoactivation process, such that another distinct subset of fluorophores can be precisely located 
within the image. By switching fluorophores ―on‖ and ―off‖ through several iterations, a composite 
image with nanoscale resolution can be reconstructed from the multiple images of sparsely activated 
fluorophores. Super-resolution microscopy which relies on stochastic photoswitching of fluorophores 
is  known  by  the  name  stochastic  optical  reconstruction  microscopy  (STORM)  [135]  (Figure  5).  
Super-resolution  microscopy  which  relies  on  photoactivation  of  fluorophores  is  referred  to  as 
photoactivation localization microscopy (PALM) [136] or fluorescence photoactivation localization 
depletion (fPALM) [137]. 
A recent application of super-resolution PALM microscopy to HIV-1 Gag molecules at the cellular 
membrane provided unique insights into membrane-bound behavior [138]. The authors developed a 
single-particle  tracking  PALM  methodology  (stPALM)  which  allowed  the  dynamic  tracking  of Viruses 2011, 3                         
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individual Gag molecules at the membrane of COS7 cells. It was found that ~67% of Gag molecules 
tracked  were  located  within  clusters  of  Gag  molecules,  consisting  of  at  least  five  Gag  molecules 
residing in an area of 300 nm. This demonstrated the resolvability of single Gag molecules within 
putative sites of VLP assembly, something unachievable with conventional microscopy techniques. 
Figure 5. Super-resolution microscopy. Super-resolution microscopy obtains fluorescence-
based spatial information with sub-diffraction (<200 nm) resolution. This is accomplished 
by using photo-activatable (PALM/fPALM) or photo-switchable (STORM) fluorophores, 
such that a sparse, spatially-separated sub-population of fluorophores is active at any one 
time.  Upon  photo-activation  of  the  sub-population,  the  positions  of  the  well-separated 
fluorophores  can  be  determined  with  high  spatial  resolution  by  mapping  the center of  
the  diffraction-limited  fluorescence  signal.  The  activated  fluorophores  are  then  
de-activated either by photobleaching (PALM/fPALM) or photo-switching, and a different 
sub-population is activated and localized. By repeating this process thousands of times, a 
composite,  super-resolution  image  can  be  constructed  using  the  mapped  position  of  
every fluorophore.  
 
8. Summary 
Two key recent advances provide much excitement in learning more about the detailed mechanisms 
of  HTLV-1  replication,  particularly  those  involving  virus  assembly,  release  as  well  as  particle 
structure and morphology. First, the development of tractable model systems has vastly improved the 
ability to conduct tissue culture-based experimentation on HTLV-1 replication. Second, the use of 
state-of-the-art  biophysical  technologies  has  tremendous  promise  in  enhancing  the  ability  to 
quantitatively investigate HTLV-1 virus assembly and release. The application of these and other 
exciting  technologies  under  development  should  lead  to  many  significant  discoveries  in  our 
understanding of these and other aspects of HTLV-1 biology, which may provide new insights into 
virus control. Viruses 2011, 3                         
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